Verastem, Inc. (VSTM)
7.22
-0.16
(-2.17%)
USD |
NASDAQ |
Aug 28, 16:00
7.22
0.00 (0.00%)
After-Hours: 20:00
Verastem Cash from Investing (Quarterly) : 16.25M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.25M |
| March 31, 2026 | -16.02M |
| December 31, 2025 | -1.345M |
| September 30, 2025 | -8.279M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 28.99M |
| March 31, 2024 | 30.98M |
| December 31, 2023 | 12.44M |
| September 30, 2023 | -70.08M |
| June 30, 2023 | 14.00M |
| March 31, 2023 | -0.804M |
| December 31, 2022 | 13.02M |
| September 30, 2022 | 4.647M |
| June 30, 2022 | 29.25M |
| March 31, 2022 | 19.26M |
| December 31, 2021 | 0.066M |
| September 30, 2021 | 10.00M |
| June 30, 2021 | 2.393M |
| March 31, 2021 | -12.37M |
| December 31, 2020 | -79.38M |
| September 30, 2020 | -0.006M |
| June 30, 2020 | -0.027M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.05M |
| December 31, 2019 | 25.13M |
| September 30, 2019 | 17.59M |
| June 30, 2019 | 46.53M |
| March 31, 2019 | 0.363M |
| December 31, 2018 | -126.80M |
| September 30, 2018 | -15.48M |
| June 30, 2018 | -0.53M |
| March 31, 2018 | 4.435M |
| December 31, 2017 | 4.509M |
| September 30, 2017 | 21.32M |
| June 30, 2017 | 14.02M |
| March 31, 2017 | 4.096M |
| December 31, 2016 | 1.027M |
| September 30, 2016 | 3.729M |
| June 30, 2016 | 31.11M |
| March 31, 2016 | 1.104M |
| December 31, 2015 | 15.19M |
| September 30, 2015 | -3.791M |
| June 30, 2015 | 8.942M |
| March 31, 2015 | -47.40M |
| December 31, 2014 | 13.48M |
| September 30, 2014 | 7.62M |
| June 30, 2014 | 17.92M |
| March 31, 2014 | 4.118M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Dianthus Therapeutics, Inc. | -478.52M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -43.91M |
| Cash from Financing (Quarterly) | -1.539M |
| Free Cash Flow | -171.82M |
| Free Cash Flow Per Share (Quarterly) | -0.4386 |
| Free Cash Flow to Equity (Quarterly) | -42.76M |
| Free Cash Flow to Firm (Quarterly) | -43.54M |
| Free Cash Flow Yield | -26.82% |